CD4 and HIV-1 infection: Therefore, we postulate that therapeutics that mimic viral target cells could prevent escape and permanently control HIV-1 infection by exposing a universal vulnerability—the requirement to bind clusters of CD4 on a target cell—that is potentially inherent to all HIV-1 strains and variants.